CADTH is launching a new Patient and Community Advisory Committee

After talks with patient groups this past fall, CADTH is creating a 12-person advisory committee to discuss the experiences of patients and family caregivers in Canada. They invite nominations for those with extensive experience as a patient or family caregiver in Canada and awareness of others’ views on using the Canadian health care system.

See here: Call for Nominations to the CADTH Patient and Community Advisory Committee.

pCODR – Upcoming consultation on the transition of the functions of CAPCA’s Cancer Drug Implementation Advisory Committee to CADTH

CADTH and CAPCA (Canadian Association of Provincial Cancer Agencies) are holding a webinar on March 4^th, 2019 to outline a proposal to transition the functions of CAPCA’s Cancer Drug Implementation Advisory Committee to CADTH. A consultation document will be issued on or before March 1^st. The consultation will be open to all stakeholders who may be interested in providing input on the proposal.

Register here before registration closes on March 1^st, 2019 at 5PM EDT.

CDR – CADTH undertakes several initiatives to enhance clinical engagement in the CDR process

To enhance CADTH’s process for establishing reimbursement criteria in CDR recommendations, CADTH is expanding engagement with physicians during reviews of complex drugs and conditions by establishing panels of clinical experts for drugs undergoing expedited review by Health Canada. Full details regarding CADTH’s procedure for the integration of clinical panels into the review phase will be incorporated into an updated procedural document (targeted to be posted in March 2019).

CADTH Symposium 2019 Registration

CADTH Symposium 2019 is being held in Edmonton, Alberta, from April 14^th to 16^th, 2019. A preliminary outline of the event is available here.

Register here.